Developmental outcome in children with intrauterine exposure to substances

H-C Steinhausen1, B Blattmann, F Pfund

  • 1Department of Child and Adolescent Psychiatry, University of Zürich, Zürich, Switzerland. steinh@kjpd.unizh.ch

Insights

Children born to mothers undergoing substance abuse treatment showed lower intellectual functioning. Intrauterine exposure to heroin and methadone significantly impacted developmental outcomes, highlighting risks associated with prenatal substance use.

Area of Science:

  • Developmental Psychology
  • Neuroscience
  • Public Health

Background:

  • Substance-dependent mothers in residential treatment pose risks to child development.
  • Prenatal exposure to substances can lead to adverse developmental outcomes.
  • Understanding specific risk factors is crucial for early intervention.

Purpose of the Study:

  • To assess the developmental outcomes of children born to substance-dependent mothers.
  • To identify biological and psychosocial risk factors associated with developmental outcomes.
  • To investigate the impact of intrauterine substance exposure on intellectual functioning.

Main Methods:

  • Studied 61 children (infancy to preadolescence) of mothers in a Swiss residential treatment program.
  • Utilized age-appropriate intelligence tests to assess developmental outcomes.
  • Analyzed associations between various biological and psychosocial risk factors and child outcomes.

Main Results:

  • Children's mean intellectual functioning was significantly lower than population norms.
  • An excess of children exhibited subnormal intellectual functioning.
  • Performance IQ was negatively associated with intrauterine substance exposure, particularly heroin and methadone, independent of other substance use.

Conclusions:

  • Intrauterine exposure to heroin and methadone negatively affects offspring developmental outcomes.
  • Prenatal substance exposure is a significant risk factor for intellectual deficits in children of substance-dependent mothers.
  • Further research and targeted interventions are needed to mitigate these developmental risks.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...